Hosted on MSN15d
MindMed Stock Skyrockets 94% Year to Date: What's Driving It?
MNMD is developing its lead pipeline candidate, MM120, an orally disintegrating tablet (ODT) and a pharmaceutically optimized ...
Geode Capital Management LLC Has $9.55 Million Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Geode Capital Management LLC boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 10.8% during ...
ETF Daily News21d
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $27.71 Consensus Price Target from Brokerages
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has earned an average recommendation of “Buy” from the eleven research firms that are covering the firm, MarketBeat.com reports.
Morningstar21d
MindMed to Be Added to the Nasdaq Biotechnology Index
Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders ...
Joplin Globe24d
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders ...
Mind Medicine首席法务官出售价值33,576美元的股票
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)的首席法务官Mark ...
Yahoo Finance21d
MindMed to Be Added to the Nasdaq Biotechnology Index
NEW YORK, December 19, 2024--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company ...
Yahoo Finance21d
MindMed to Be Added to the Nasdaq Biotechnology Index
NEW YORK, December 19, 2024--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates ...